Catalysis in non--local quantum operations

We show how entanglement can be used, without being consumed, to accomplish unitary operations that could not be performed with out it. When applied to infinitesimal transformations our method makes equivalent, in the sense of Hamiltonian simulation, a whole class of otherwise inequivalent two-qubit interactions. The new catalysis effect also implies the asymptotic equivalence of all such interactions.Comment: 4 pages, revte

Strong nonlocality: A trade-off between states and measurements

Measurements on entangled quantum states can produce outcomes that are nonlocally correlated. But according to Tsirelson's theorem, there is a quantitative limit on quantum nonlocality. It is interesting to explore what would happen if Tsirelson's bound were violated. To this end, we consider a model that allows arbitrary nonlocal correlations, colloquially referred to as "box world". We show that while box world allows more highly entangled states than quantum theory, measurements in box world are rather limited. As a consequence there is no entanglement swapping, teleportation or dense coding.Comment: 11 pages, 2 figures, very minor change

Estimating the financial impact of gene therapy in the U.S.

We empirically assess the potential financial impact of future gene therapies on the US economy. After identifying 109 late-stage gene therapy clinical trials currently underway, we estimate the number of new and existing patients with corresponding diseases to be treated by these gene therapies, developing and applying novel mathematical models to estimate the increase in quality-adjusted life years for each approved gene therapy. We then simulate the launch prices and the expected spending for these therapies over a 15-year time horizon. Under conservative assumptions, the results of our simulation suggest that an expected total of 1.09 million patients will be treated by gene therapy from January 2020 to December 2034. The expected peak annual spending on these therapies is $25.3 billion, and the expected total spending from January 2020 to December 2034 is$306 billion. Assuming a linear pace of future gene therapy development fitted to past experience, our spending estimate increases by only 15.7% under conservative assumptions. As a proxy for the impact of expected spending on different public and private payers, we decompose the estimated annual spending by treated age group. Since experience suggests that insurers with annual budget constraints may restrict access to therapies with expected benefit to the patient, we consider various methods of payment to ensure access to these therapies even among those insured by the most budget-constrained payers.https://www.nber.org/papers/w28628First author draf

Highly efficient single-layer dendrimer light-emitting diodes with balanced charge transport

Published versio

CD90 is not constitutively expressed in functional innate lymphoid cells

Huge progress has been made in understanding the biology of innate lymphoid cells (ILC) by adopting several well-known concepts in T cell biology. As such, flow cytometry gating strategies and markers, such as CD90, have been applied to indentify ILC. Here, we report that most non-NK intestinal ILC have a high expression of CD90 as expected, but surprisingly a sub-population of cells exhibit low or even no expression of this marker. CD90-negative and CD90-low CD127+ ILC were present amongst all ILC subsets in the gut. The frequency of CD90-negative and CD90-low CD127+ ILC was dependent on stimulatory cues in vitro and enhanced by dysbiosis in vivo. CD90-negative and CD90-low CD127+ ILC were a potential source of IL-13, IFNγ and IL-17A at steady state and upon dysbiosis- and dextran sulphate sodium-elicited colitis. Hence, this study reveals that, contrary to expectations, CD90 is not constitutively expressed by functional ILC in the gut

Conjugated dendrimers: A modular approach to materials for full colour displays

Conjugated dendrimers provide an excellent molecular architecture for tuning material properties for organic light emitting diodes. Here we demonstrate a modular approach allowing highly efficient fluorescent and phosphorescent emissive chromophores to be used to make red, green and blue solution-processed light emitting diodes. The choice of a common dendritic architecture ensures good solubility and film forming properties irrespective of the choice of core unit. In addition, this architecture allows blending of dendrimers with different cores without phase separation. We show that blending provides a simple but powerful way of tuning the colour of dendrimer LEDs from deep blue to blue-green, and from green to red with little impact on the device properties

Classification of multipartite entangled states by multidimensional determinants

We find that multidimensional determinants "hyperdeterminants", related to entanglement measures (the so-called concurrence or 3-tangle for the 2 or 3 qubits, respectively), are derived from a duality between entangled states and separable states. By means of the hyperdeterminant and its singularities, the single copy of multipartite pure entangled states is classified into an onion structure of every closed subset, similar to that by the local rank in the bipartite case. This reveals how inequivalent multipartite entangled classes are partially ordered under local actions. In particular, the generic entangled class of the maximal dimension, distinguished as the nonzero hyperdeterminant, does not include the maximally entangled states in Bell's inequalities in general (e.g., in the $n \geq 4$ qubits), contrary to the widely known bipartite or 3-qubit cases. It suggests that not only are they never locally interconvertible with the majority of multipartite entangled states, but they would have no grounds for the canonical n-partite entangled states. Our classification is also useful for the mixed states.Comment: revtex4, 10 pages, 4 eps figures with psfrag; v2 title changed, 1 appendix added, to appear in Phys. Rev.

Using Transitional Changes on Highâ Resolution Computed Tomography to Monitor the Impact of Cyclophosphamide or Mycophenolate Mofetil on Systemic Sclerosisâ Related Interstitial Lung Disease

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/153695/1/art41085.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/153695/2/art41085_am.pd

Cyclin-dependent kinase 9 as a potential target for anti-TNF resistant inflammatory bowel disease

BACKGROUND AND AIMS: Resistance to single cytokine blockade, namely anti-TNF therapy, is a growing concern for patients with inflammatory bowel disease (IBD). The transcription factor T-bet is a critical regulator of intestinal homeostasis, is genetically linked to mucosal inflammation and controls the expression of multiples genes such as the pro-inflammatory cytokines IFN-γ and TNF. Inhibiting T-bet may therefore offer a more attractive prospect for treating IBD but remains challenging to target therapeutically. In this study, we evaluate the effect of targeting the transactivation function of T-bet using inhibitors of P-TEFb (CDK9-cyclin T), a transcriptional elongation factor downstream of T-bet. METHODS: Using an adaptive immune-mediated colitis model, human colonic lymphocytes from IBD patients and multiple large clinical datasets, we investigate the effect of CDK9 inhibitors on cytokine production and gene expression in colonic CD4+ T cells and link these genetic modules to clinical response in patients with IBD. RESULTS: Systemic CDK9 inhibition led to histological improvement of immune-mediated colitis and was associated with targeted suppression of colonic CD4+ T cell-derived IFN-γ and IL-17A. In colonic lymphocytes from IBD patients, CDK9 inhibition potently repressed genes responsible for pro-inflammatory signalling, and in particular genes regulated by T-bet. Remarkably, CDK9 inhibition targeted genes that were highly expressed in anti-TNF resistant IBD and that predicted non-response to anti-TNF therapy. CONCLUSION: Collectively, our findings reveal CDK9 as a potential target for anti-TNF resistant IBD, which has the potential for rapid translation to the clinic